IBDEI1MF ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.4) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.4,1123,0)
;;=QUALIFYING CIRCUMSTANCES^16^86
;;^UTILITY(U,$J,358.4,1124,0)
;;=TEAM CONFERENCE^21^86
;;^UTILITY(U,$J,358.4,1125,0)
;;=COVID-19 CONFIRMED^2^87
;;^UTILITY(U,$J,358.4,1126,0)
;;=COVID-19 EXPOSURE^3^87
;;^UTILITY(U,$J,358.4,1127,0)
;;=COVID-19 RELATED COND/SYMP^5^87
;;^UTILITY(U,$J,358.4,1128,0)
;;=COVID-19 SCREEN^1^87
;;^UTILITY(U,$J,358.4,1129,0)
;;=COVID-19 PRE-OP^4^87
;;^UTILITY(U,$J,358.4,1130,0)
;;=COVID-19 ^1^88
;;^UTILITY(U,$J,358.4,1131,0)
;;=COVID-19 CONFIRMED^2^89
;;^UTILITY(U,$J,358.4,1132,0)
;;=COVID-19 EXPOSURE^3^89
;;^UTILITY(U,$J,358.4,1133,0)
;;=COVID-19 RELATED COND/SYMP^5^89
;;^UTILITY(U,$J,358.4,1134,0)
;;=COVID-19 SCREEN^1^89
;;^UTILITY(U,$J,358.4,1135,0)
;;=COVID-19 PRE-OP^4^89
;;^UTILITY(U,$J,358.4,1136,0)
;;=ESTABLISHED PATIENT^1^90
;;^UTILITY(U,$J,358.4,1137,0)
;;=GROUP PSYCHOTHERAPY/INTERVENTION^2^91
;;^UTILITY(U,$J,358.4,1138,0)
;;=OTHER^10^91
;;^UTILITY(U,$J,358.4,1139,0)
;;=TEAM CONFERENCE^9^91
;;^UTILITY(U,$J,358.4,1140,0)
;;=SUBSTANCE ABUSE^8^91
;;^UTILITY(U,$J,358.4,1141,0)
;;=CASE MANAGEMENT^1^91
;;^UTILITY(U,$J,358.4,1142,0)
;;=INJECTION ADMINISTRATION^6^91
;;^UTILITY(U,$J,358.4,1143,0)
;;=INJECTIONS/MEDICATIONS^7^91
;;^UTILITY(U,$J,358.4,1144,0)
;;=IN-HOME BEHAVIOR/HEALTH ASSESSMENT^5^91
;;^UTILITY(U,$J,358.4,1145,0)
;;=IMMUNIZATION ADMINISTRATION ^3^91
;;^UTILITY(U,$J,358.4,1146,0)
;;=IMMUNIZATIONS^4^91
;;^UTILITY(U,$J,358.4,1147,0)
;;=ABUSE,NEGLECT, & VIOLENCE^1^92
;;^UTILITY(U,$J,358.4,1148,0)
;;=ANXIETY DISORDERS^2^92
;;^UTILITY(U,$J,358.4,1149,0)
;;=BIPOLAR & RELATED DISORDERS^3^92
;;^UTILITY(U,$J,358.4,1150,0)
;;=NEUROCOGNITIVE DISORDERS^18^92
;;^UTILITY(U,$J,358.4,1151,0)
;;=DEPRESSIVE DISORDERS^8^92
;;^UTILITY(U,$J,358.4,1152,0)
;;=DISSOCIATIVE DISORDERS ^10^92
;;^UTILITY(U,$J,358.4,1153,0)
;;=FEEDING & EATING DISORDERS^13^92
;;^UTILITY(U,$J,358.4,1154,0)
;;=EDUC/OCCUPATIONAL PROBLEMS^11^92
;;^UTILITY(U,$J,358.4,1155,0)
;;=GENDER DYSPHORIA^15^92
;;^UTILITY(U,$J,358.4,1156,0)
;;=HOUSING/ECONOMIC PROBLEMS^16^92
;;^UTILITY(U,$J,358.4,1157,0)
;;=MEDICATION ADVERSE EFFECTS^17^92
;;^UTILITY(U,$J,358.4,1158,0)
;;=OBSESSIVE-COMPULSIVE & RELATED DISORDERS^20^92
;;^UTILITY(U,$J,358.4,1159,0)
;;=PERSONAL HX & CURRENT CIRCUMSTANCES^23^92
;;^UTILITY(U,$J,358.4,1160,0)
;;=COUNSELING/MEDICAL ADVICE^5^92
;;^UTILITY(U,$J,358.4,1161,0)
;;=SOCIAL ENVIRONMENT PROBLEMS^30^92
;;^UTILITY(U,$J,358.4,1162,0)
;;=PARAPHILIC DISORDERS^22^92
;;^UTILITY(U,$J,358.4,1163,0)
;;=PERSONALITY DISORDERS^24^92
;;^UTILITY(U,$J,358.4,1164,0)
;;=CRIME/LEGAL SYSTEM PROBLEMS^6^92
;;^UTILITY(U,$J,358.4,1165,0)
;;=PSYCHOSOCIAL/PERSONAL/ENVIRONMENTAL^25^92
;;^UTILITY(U,$J,358.4,1166,0)
;;=RELATIONAL PROBLEMS^26^92
;;^UTILITY(U,$J,358.4,1167,0)
;;=SCHIZOPHRENIA/OTH PSYCHOTIC DISORDERS^27^92
;;^UTILITY(U,$J,358.4,1168,0)
;;=SEXUAL DYSFUNCTIONS^28^92
;;^UTILITY(U,$J,358.4,1169,0)
;;=SLEEP-WAKE DISORDERS^29^92
;;^UTILITY(U,$J,358.4,1170,0)
;;=SUBSTANCE DISORDER-ALCOHOL^32^92
;;^UTILITY(U,$J,358.4,1171,0)
;;=SUBSTANCE DISORDER-CANNABIS^34^92
;;^UTILITY(U,$J,358.4,1172,0)
;;=SUBSTANCE DISORDER-HALLUCINOGEN^35^92
;;^UTILITY(U,$J,358.4,1173,0)
;;=SUBSTANCE DISORDER-OPIOID^37^92
;;^UTILITY(U,$J,358.4,1174,0)
;;=SUBSTANCE DISORDER-SEDATIVE/HYPNOTIC^38^92
;;^UTILITY(U,$J,358.4,1175,0)
;;=SUBSTANCE DISORDER-TOBACCO^40^92
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1MF 3764 printed Sep 23, 2025@19:47:34 Page 2
IBDEI1MF ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.4)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.4,1123,0)
+2 ;;=QUALIFYING CIRCUMSTANCES^16^86
+3 ;;^UTILITY(U,$J,358.4,1124,0)
+4 ;;=TEAM CONFERENCE^21^86
+5 ;;^UTILITY(U,$J,358.4,1125,0)
+6 ;;=COVID-19 CONFIRMED^2^87
+7 ;;^UTILITY(U,$J,358.4,1126,0)
+8 ;;=COVID-19 EXPOSURE^3^87
+9 ;;^UTILITY(U,$J,358.4,1127,0)
+10 ;;=COVID-19 RELATED COND/SYMP^5^87
+11 ;;^UTILITY(U,$J,358.4,1128,0)
+12 ;;=COVID-19 SCREEN^1^87
+13 ;;^UTILITY(U,$J,358.4,1129,0)
+14 ;;=COVID-19 PRE-OP^4^87
+15 ;;^UTILITY(U,$J,358.4,1130,0)
+16 ;;=COVID-19 ^1^88
+17 ;;^UTILITY(U,$J,358.4,1131,0)
+18 ;;=COVID-19 CONFIRMED^2^89
+19 ;;^UTILITY(U,$J,358.4,1132,0)
+20 ;;=COVID-19 EXPOSURE^3^89
+21 ;;^UTILITY(U,$J,358.4,1133,0)
+22 ;;=COVID-19 RELATED COND/SYMP^5^89
+23 ;;^UTILITY(U,$J,358.4,1134,0)
+24 ;;=COVID-19 SCREEN^1^89
+25 ;;^UTILITY(U,$J,358.4,1135,0)
+26 ;;=COVID-19 PRE-OP^4^89
+27 ;;^UTILITY(U,$J,358.4,1136,0)
+28 ;;=ESTABLISHED PATIENT^1^90
+29 ;;^UTILITY(U,$J,358.4,1137,0)
+30 ;;=GROUP PSYCHOTHERAPY/INTERVENTION^2^91
+31 ;;^UTILITY(U,$J,358.4,1138,0)
+32 ;;=OTHER^10^91
+33 ;;^UTILITY(U,$J,358.4,1139,0)
+34 ;;=TEAM CONFERENCE^9^91
+35 ;;^UTILITY(U,$J,358.4,1140,0)
+36 ;;=SUBSTANCE ABUSE^8^91
+37 ;;^UTILITY(U,$J,358.4,1141,0)
+38 ;;=CASE MANAGEMENT^1^91
+39 ;;^UTILITY(U,$J,358.4,1142,0)
+40 ;;=INJECTION ADMINISTRATION^6^91
+41 ;;^UTILITY(U,$J,358.4,1143,0)
+42 ;;=INJECTIONS/MEDICATIONS^7^91
+43 ;;^UTILITY(U,$J,358.4,1144,0)
+44 ;;=IN-HOME BEHAVIOR/HEALTH ASSESSMENT^5^91
+45 ;;^UTILITY(U,$J,358.4,1145,0)
+46 ;;=IMMUNIZATION ADMINISTRATION ^3^91
+47 ;;^UTILITY(U,$J,358.4,1146,0)
+48 ;;=IMMUNIZATIONS^4^91
+49 ;;^UTILITY(U,$J,358.4,1147,0)
+50 ;;=ABUSE,NEGLECT, & VIOLENCE^1^92
+51 ;;^UTILITY(U,$J,358.4,1148,0)
+52 ;;=ANXIETY DISORDERS^2^92
+53 ;;^UTILITY(U,$J,358.4,1149,0)
+54 ;;=BIPOLAR & RELATED DISORDERS^3^92
+55 ;;^UTILITY(U,$J,358.4,1150,0)
+56 ;;=NEUROCOGNITIVE DISORDERS^18^92
+57 ;;^UTILITY(U,$J,358.4,1151,0)
+58 ;;=DEPRESSIVE DISORDERS^8^92
+59 ;;^UTILITY(U,$J,358.4,1152,0)
+60 ;;=DISSOCIATIVE DISORDERS ^10^92
+61 ;;^UTILITY(U,$J,358.4,1153,0)
+62 ;;=FEEDING & EATING DISORDERS^13^92
+63 ;;^UTILITY(U,$J,358.4,1154,0)
+64 ;;=EDUC/OCCUPATIONAL PROBLEMS^11^92
+65 ;;^UTILITY(U,$J,358.4,1155,0)
+66 ;;=GENDER DYSPHORIA^15^92
+67 ;;^UTILITY(U,$J,358.4,1156,0)
+68 ;;=HOUSING/ECONOMIC PROBLEMS^16^92
+69 ;;^UTILITY(U,$J,358.4,1157,0)
+70 ;;=MEDICATION ADVERSE EFFECTS^17^92
+71 ;;^UTILITY(U,$J,358.4,1158,0)
+72 ;;=OBSESSIVE-COMPULSIVE & RELATED DISORDERS^20^92
+73 ;;^UTILITY(U,$J,358.4,1159,0)
+74 ;;=PERSONAL HX & CURRENT CIRCUMSTANCES^23^92
+75 ;;^UTILITY(U,$J,358.4,1160,0)
+76 ;;=COUNSELING/MEDICAL ADVICE^5^92
+77 ;;^UTILITY(U,$J,358.4,1161,0)
+78 ;;=SOCIAL ENVIRONMENT PROBLEMS^30^92
+79 ;;^UTILITY(U,$J,358.4,1162,0)
+80 ;;=PARAPHILIC DISORDERS^22^92
+81 ;;^UTILITY(U,$J,358.4,1163,0)
+82 ;;=PERSONALITY DISORDERS^24^92
+83 ;;^UTILITY(U,$J,358.4,1164,0)
+84 ;;=CRIME/LEGAL SYSTEM PROBLEMS^6^92
+85 ;;^UTILITY(U,$J,358.4,1165,0)
+86 ;;=PSYCHOSOCIAL/PERSONAL/ENVIRONMENTAL^25^92
+87 ;;^UTILITY(U,$J,358.4,1166,0)
+88 ;;=RELATIONAL PROBLEMS^26^92
+89 ;;^UTILITY(U,$J,358.4,1167,0)
+90 ;;=SCHIZOPHRENIA/OTH PSYCHOTIC DISORDERS^27^92
+91 ;;^UTILITY(U,$J,358.4,1168,0)
+92 ;;=SEXUAL DYSFUNCTIONS^28^92
+93 ;;^UTILITY(U,$J,358.4,1169,0)
+94 ;;=SLEEP-WAKE DISORDERS^29^92
+95 ;;^UTILITY(U,$J,358.4,1170,0)
+96 ;;=SUBSTANCE DISORDER-ALCOHOL^32^92
+97 ;;^UTILITY(U,$J,358.4,1171,0)
+98 ;;=SUBSTANCE DISORDER-CANNABIS^34^92
+99 ;;^UTILITY(U,$J,358.4,1172,0)
+100 ;;=SUBSTANCE DISORDER-HALLUCINOGEN^35^92
+101 ;;^UTILITY(U,$J,358.4,1173,0)
+102 ;;=SUBSTANCE DISORDER-OPIOID^37^92
+103 ;;^UTILITY(U,$J,358.4,1174,0)
+104 ;;=SUBSTANCE DISORDER-SEDATIVE/HYPNOTIC^38^92
+105 ;;^UTILITY(U,$J,358.4,1175,0)
+106 ;;=SUBSTANCE DISORDER-TOBACCO^40^92
